Henry Schein, Inc. (HSIC)HSICHenry Schein, Inc.

Financials

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024	Quarter ended Jun 2024
Revenue	13.38B	3.37B	3.44B	3.34B	3.24B	3.17B	3.19B	3.17B	3.14B
Cost of Goods Sold	9.41B	2.30B	2.44B	2.38B	2.29B	2.23B	2.26B	2.25B	2.18B
Gross Profit	3.97B	1.07B	994.00M	958.00M	952.00M	938.00M	930.00M	929.00M	955.00M
Gross Profit Margin	29.7%	31.8%	28.9%	28.7%	29.4%	29.6%	29.1%	29.3%	30.5%
Total Operating Expenses	3.23B	888.00M	808.00M	752.00M	777.00M	736.00M	738.00M	724.00M	781.00M
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	3.15B	809.00M	808.00M	752.00M	777.00M	736.00M	738.00M	724.00M	781.00M
Operating Income (EBIT)	749.00M	182.00M	186.00M	206.00M	175.00M	202.00M	192.00M	205.00M	174.00M
Operating Margin	5.6%	5.4%	5.4%	6.2%	5.4%	6.4%	6.0%	6.5%	5.5%
Income Before Tax (EBT)	547.00M	150.00M	135.00M	137.00M	125.00M	148.00M	127.00M	131.00M	138.00M
Interest Income	34.00M	7.00M	9.00M	9.00M	9.00M	6.00M	6.00M	7.00M	6.00M
Interest Expense	154.00M	39.00M	39.00M	38.00M	38.00M	35.00M	35.00M	34.00M	32.00M
Other Income/Expense	-202.00M	-32.00M	-51.00M	-69.00M	-50.00M	-54.00M	-65.00M	-74.00M	-36.00M
Net Income	395.00M	107.00M	101.00M	101.00M	86.00M	110.00M	94.00M	99.00M	104.00M
Income Tax Expense	129.00M	38.00M	32.00M	28.00M	31.00M	35.00M	31.00M	32.00M	33.00M
Net Profit Margin	3.0%	3.2%	2.9%	3.0%	2.7%	3.5%	2.9%	3.1%	3.3%
EBITDA	1.05B	249.00M	268.00M	286.00M	251.00M	275.00M	268.00M	279.00M	248.00M
EBITDA Margin	7.9%	7.4%	7.8%	8.6%	7.7%	8.7%	8.4%	8.8%	7.9%
Depreciation & Amortization	305.00M	67.00M	82.00M	80.00M	76.00M	73.00M	76.00M	74.00M	74.00M
EPS Basic	3.34	0.93	0.86	0.84	0.71	0.89	0.75	0.79	0.81
EPS Diluted	3.31	0.92	0.85	0.84	0.70	0.88	0.74	0.78	0.80
Shares Outstanding	114.94M	114.94M	117.36M	120.24M	121.93M	123.78M	124.51M	126.12M	127.78M
Diluted Shares Outstanding	116.06M	116.06M	118.34M	121.04M	122.64M	124.85M	125.63M	127.05M	128.65M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/27/2025	12/28/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	13.18B	12.67B	12.34B	12.65B	12.40B	10.12B	9.99B	13.20B
Cost of Goods Sold	9.34B	8.91B	8.69B	9.00B	8.73B	7.30B	6.89B	6.51B
Gross Profit	3.84B	3.77B	3.65B	3.65B	3.67B	2.81B	3.09B	2.91B
Gross Profit Margin	29.1%	29.7%	29.6%	28.9%	29.6%	27.8%	31.0%	22.0%
Total Operating Expenses	3.08B	3.04B	2.94B	2.71B	2.82B	2.25B	2.36B	2.22B
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	3.08B	3.04B	2.94B	2.71B	2.82B	2.25B	2.36B	2.22B
Operating Income (EBIT)	758.00M	729.00M	714.00M	938.00M	854.81M	567.40M	732.97M	693.47M
Operating Margin	5.7%	5.8%	5.8%	7.4%	6.9%	5.6%	7.3%	5.3%
Income Before Tax (EBT)	545.00M	526.00M	556.00M	736.00M	850.56M	512.24M	698.21M	557.87M
Interest Income	33.00M	24.00M	17.00M	17.00M	6.45M	9.84M	15.76M	15.49M
Interest Expense	150.00M	131.00M	87.00M	44.00M	27.60M	41.38M	50.79M	76.02M
Other Income/Expense	-213.00M	-203.00M	-158.00M	-202.00M	-4.25M	-55.16M	-34.76M	-135.60M
Net Income	398.00M	390.00M	416.00M	538.00M	623.91M	402.22M	507.96M	535.88M
Income Tax Expense	126.00M	128.00M	120.00M	170.00M	197.35M	95.37M	159.51M	107.43M
Net Profit Margin	3.0%	3.1%	3.4%	4.3%	5.0%	4.0%	5.1%	4.1%
EBITDA	1.07B	1.03B	962.00M	1.15B	1.06B	752.93M	917.91M	837.10M
EBITDA Margin	8.1%	8.1%	7.8%	9.1%	8.6%	7.4%	9.2%	6.3%
Depreciation & Amortization	311.00M	297.00M	248.00M	212.00M	209.53M	185.54M	184.94M	143.63M
EPS Basic	3.29	3.07	3.18	3.95	4.51	2.82	3.44	3.51
EPS Diluted	3.27	3.05	3.16	3.91	4.45	2.80	3.40	3.49
Shares Outstanding	120.81M	126.79M	130.62M	136.06M	140.09M	142.50M	147.82M	152.66M
Diluted Shares Outstanding	121.72M	127.78M	131.75M	137.76M	141.77M	143.40M	149.26M	153.71M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Henry Schein, Inc.

Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.

Melville, NY

25,000 employees

www.henryschein.com

Healthcare / Medical - Distribution

Sector: Healthcare
Industry: Medical - Distribution
CEO: Frederick Lowery

View full financials